Autopsy report · NCT00281879
Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer
Cause of deathNo reason given
Life of this trial
- Ran for about 2 years 1 month before it stopped.
- 200 participants enrolled.
- Results were posted on the registry 4 years 3 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- OHSU Knight Cancer Institute
- Sponsor type
- University, hospital or other
- Conditions
- Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms
- Interventions
- anti-thymocyte globulin; filgrastim; busulfan; carmustine; cyclophosphamide; cyclosporine
- Participants
- 200
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.